PRF Technologies (PRFX) Stock Price, Quote, News & History

PRF Technologies Ltd (PRFX) Stock Price, Quote, News & History

PRFXNASDAQ

Trade with Public

$2.67

0.051.91%

At close: Mar 9, 5:00 PM EST

$2.75

0.134.96%

Pre-Market: 7:53 AM EST

Key Statistics

Open

$2.67

Volume / Avg.

227.00 / 530.05K

Day Range

- - -

52 Wk Range

2.50 - 17.95

Market Cap

$2.15M

P/E Ratio

0.02

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

31.74%

Days to Cover

Recent PRF Technologies Ltd News

Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push

PainReform stock surges on heavy volume after PainReform rebranded as PRF Technologies.

Vandana Singh

Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.96M

Investing Cash Flow (TTM)

-51.00K

Financing Cash Flow (TTM)

6.70M

Free Cash Flow (TTM)

-5.96M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

690.00K

Valuation Metrics

Enterprise Value

-$1.33M

PE Ratio (TTM)

0.02

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.25

Earnings Yield % (TTM)

5599.25%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$10.78

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.48M

Debt to Equity

0.01

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.67

Volume / Avg.

227.00 / 530.05K

Day Range

- - -

52 Wk Range

2.50 - 17.95

Market Cap

$2.15M

P/E Ratio

0.02

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

31.74%

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustaine...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy PRF Technologies (PRFX) stock?

You can purchase shares of PRF Technologies (NASDAQ:PRFX) through any online brokerage.

View our list of the best stock brokerages

Who are PRF Technologies (PRFX) competitors?

Other companies in PRF Technologies’s space includes: Processa Pharmaceuticals Inc (NASDAQ:PCSA), cbdMD Inc (AMEX:YCBD), IM Cannabis Corp (NASDAQ:IMCC), 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) and InMed Pharmaceuticals Inc (NASDAQ:INM).

What is the forecast, or price target, for PRF Technologies (PRFX) stock?

There is no analysis for PRF Technologies to provide a consensus price target.

What is the current price for PRF Technologies (PRFX)?

The stock price for PRF Technologies (NASDAQ: PRFX) is $2.75 last updated March 10, 2026 at 4:45 PM EDT.

Does PRF Technologies (PRFX) pay a dividend?

There are no upcoming dividends for PRF Technologies.

When is PRF Technologies (NASDAQ:PRFX) reporting earnings?

PRF Technologies does not have any upcoming earnings scheduled.

Is PRF Technologies (PRFX) going to split?

There is no upcoming split for PRF Technologies.

What sector and industry does PRF Technologies (PRFX) operate in?

PRF Technologies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Processa Pharmaceuticals Inc

60 Degrees Pharmaceuticals Inc

NASDAQ:SXTP

$2.12

11.32%

InMed Pharmaceuticals Inc

Universe Pharmaceuticals Inc

Key Statistics

Open

$2.67

Volume / Avg.

227.00 / 530.05K

Day Range

- - -

52 Wk Range

2.50 - 17.95

Market Cap

$2.15M

P/E Ratio

0.02

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

31.74%

Days to Cover

Recent PRF Technologies Ltd News

Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push

PainReform stock surges on heavy volume after PainReform rebranded as PRF Technologies.

Vandana Singh

Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.96M

Investing Cash Flow (TTM)

-51.00K

Financing Cash Flow (TTM)

6.70M

Free Cash Flow (TTM)

-5.96M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

690.00K

Valuation Metrics

Enterprise Value

-$1.33M

PE Ratio (TTM)

0.02

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.25

Earnings Yield % (TTM)

5599.25%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$10.78

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.48M

Debt to Equity

0.01

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.67

Volume / Avg.

227.00 / 530.05K

Day Range

- - -

52 Wk Range

2.50 - 17.95

Market Cap

$2.15M

P/E Ratio

0.02

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

31.74%

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry